KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Assets (2016 - 2025)

Historic Assets for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $2.9 billion.

  • Teladoc Health's Assets fell 1842.2% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year decrease of 1842.2%. This contributed to the annual value of $3.5 billion for FY2024, which is 1994.02% down from last year.
  • Per Teladoc Health's latest filing, its Assets stood at $2.9 billion for Q3 2025, which was down 1842.2% from $2.9 billion recorded in Q2 2025.
  • Teladoc Health's Assets' 5-year high stood at $17.7 billion during Q4 2021, with a 5-year trough of $2.9 billion in Q3 2025.
  • Over the past 5 years, Teladoc Health's median Assets value was $4.3 billion (recorded in 2023), while the average stood at $7.6 billion.
  • As far as peak fluctuations go, Teladoc Health's Assets skyrocketed by 99678.81% in 2021, and later plummeted by 7549.79% in 2022.
  • Quarter analysis of 5 years shows Teladoc Health's Assets stood at $17.7 billion in 2021, then plummeted by 75.5% to $4.3 billion in 2022, then rose by 1.08% to $4.4 billion in 2023, then decreased by 19.94% to $3.5 billion in 2024, then dropped by 18.14% to $2.9 billion in 2025.
  • Its Assets was $2.9 billion in Q3 2025, compared to $2.9 billion in Q2 2025 and $3.4 billion in Q1 2025.